Clover Health Investments, Corp.
Every calculator, already run for CLOV
Open the full toolkit →You have the numbers on CLOV. Get the argument.
A written report on which of these readings actually decide the outcome for Clover Health Investments, Corp., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
4 analysts covering CLOVAnalyst Price Target Disagreement for Clover Health Investments, Corp.
Wall Street's bull case implies +39% from the current price; the bear case implies +15%. Analysts are relatively aligned on CLOV's range.
Ownership & short interest
Insider Trading Activity for CLOV
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Clover Health Investments, Corp.
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
CLOV — frequently asked
Is CLOV a buy right now?
Wall Street's consensus rating on Clover Health Investments, Corp. is none across 4 analysts, with a mean price target of $5.38 (+24% vs. the current $4.33). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is CLOV overvalued?
CLOV trades at — trailing earnings, against a DCF fair value of $1 per share. The current price implies 24% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is CLOV's next earnings date?
Clover Health Investments, Corp. is next scheduled to report earnings around Nov 4, 2026. A full CLOV research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Clover Health Investments, Corp.?
Analysts covering Clover Health Investments, Corp. (CLOV) range from a bear-case target of $5.00 to a bull-case high of $6.00, with a mean consensus target of $5.38 across 4 analysts. The spread of $1.00 (23% of the current price) indicates moderate disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Clover Health Investments, Corp. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Clover Health Investments, Corp.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full CLOV research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Clover Health Investments, Corp., in minutes. 3 free reports included with every account — no credit card required.